Menu Close

Articles on SARS-CoV-2

Displaying 161 - 180 of 583 articles

High-touch surfaces in grocery stores were tested as a potential transmission point for SARS-CoV-2. THE CANADIAN PRESS/Christopher Katsarov 

Testing high-touch surfaces in grocery stores for COVID-19

The risk of COVID-19 exposure from high-touch surfaces within grocery stores is low if physical distancing guidelines and recommended cleaning protocols are followed.
Several thousand protestors opposed to the COVID-19 vaccine march through the streets of midtown Manhattan in New York on Sept. 18, 2021. Andrew Lichtenstein/Corbis News via Getty Images

Can healthy people who eat right and exercise skip the COVID-19 vaccine? A research scientist and fitness enthusiast explains why the answer is no

A growing body of research shows that nutrition, sleep, exercise and a host of other lifestyle choices can help optimize the immune system. But they are no substitute for life-saving vaccines.
Aerial view of the UK’s national synchrotron, Diamond Light Source Ltd (Diamond) on the Harwell Science and Innovation Campus in Oxfordshire, ©Diamond Light Source

Want to develop vaccines in Africa? Then invest in expertise and infrastructure

Making vaccines in South Africa by building on the foundation that’s been laid is possible. But only if substantial and sustained investment in human resources and infrastructure becomes a reality.
In the reluctance to vaccinate, there is a lack of trust and understanding of the scientific process. Better communication would help rebuild bridges. The Canadian Press/Paul Chiasson

A researcher’s view on COVID-19 vaccine hesitancy: The scientific process needs to be better explained

Before the pandemic, the public perceived science as infallible and inaccessible. But the opening up of research to the general public has changed that perception.
The huge number of active coronavirus infections offers plenty of opportunity for mutations to occur and new variants to arise. Eoneren/E+ via Getty Images

Massive numbers of new COVID–19 infections, not vaccines, are the main driver of new coronavirus variants

When the coronavirus copies itself, there is a chance its RNA will mutate. But new variants must jump from one host to another, and the more infections there are, the better chance this will happen.
People getting vaccinated may still have questions about COVID-19 vaccines, like why it takes two doses — and then two weeks — to take full effect. THE CANADIAN PRESS/Ryan Remiorz

I work at a COVID-19 vaccine clinic. Here’s what people ask me when they’re getting their shot — and what I tell them

A medical student answers questions he gets asked at a COVID-19 vaccine clinic: Efficacy versus real-world effectiveness, immune response and how the mRNA vaccines compare to vaccines already in wide use.
By better communicating how vaccines boost the immune system’s long term “memory”, manufacturers could address vaccine hesitancy. i_am_zews/Shutterstock

COVID-19 vaccines produce T-cell immunity that lasts and works against virus variants

Cell-mediated immunity is particularly effective at eradicating viruses, and more durable. This is important in the fight against COVID-19.

Top contributors

More